Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosis

Maëlle Chappuis, Chloé Rousseau, Emma Bajeux, Sandrine Wiertlewski, David Laplaud, Emmanuelle Le Page, Laure Michel, Gilles Edan, Anne Kerbrat